I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Funda Meric-Bernstam
842
results:
Search for persons
X
Format
Online (842)
Mediatypes
Articles (Online) (377)
Bookchapter (Online) (6)
OpenAccess-fulltext (459)
Sorted by: Relevance
Sorted by: Year
?
1
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Var..:
Pilié, Patrick G.
;
Giuliani, Virginia
;
Wang, Wei-Lien
...
Clinical Cancer Research. 30 (2024) 10 - p. 2121-2139 , 2024
Link:
https://doi.org/10.1158/..
?
2
Assessment of Patient-Derived Xenograft Growth and Antitumo..:
Meric-Bernstam, Funda
;
Lloyd, Michael W.
;
Koc, Soner
...
Molecular Cancer Therapeutics. 23 (2024) 7 - p. 924-938 , 2024
Link:
https://doi.org/10.1158/..
?
3
Phase II study of talazoparib in advanced cancers with BRCA..:
Piha-Paul, Sarina A.
;
Tseng, Chieh
;
Leung, Cheuk Hong
...
npj Precision Oncology. 8 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
First-In-Human Phase I Study of Tinengotinib (TT-00420), a ..:
Piha-Paul, Sarina A
;
Xu, Binghe
;
Dumbrava, Ecaterina E
...
The Oncologist. 29 (2024) 4 - p. e514-e525 , 2024
Link:
https://doi.org/10.1093/..
?
5
Safety Profile and Adverse Event Management for Futibatinib..:
Meric-Bernstam, Funda
;
Hollebecque, Antoine
;
Furuse, Junji
...
Clinical Cancer Research. 30 (2024) 8 - p. 1466-1477 , 2024
Link:
https://doi.org/10.1158/..
?
6
Adaptive Darwinian off-target resistance mechanisms to sele..:
Subbiah, Vivek
;
Gouda, Mohamed A.
;
Iorgulescu, J. Bryan
...
npj Precision Oncology. 8 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
7
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Za..:
DiPeri, Timothy P.
;
Evans, Kurt W.
;
Wang, Bailiang
...
Cancer Discovery. 14 (2024) 5 - p. 828-845 , 2024
Link:
https://doi.org/10.1158/..
?
8
Heterogeneous Profile of ROR1 Protein Expression across Tum..:
Raso, Maria Gabriela
;
Barrientos Toro, Elizve
;
Evans, Kurt
...
Cancers. 16 (2024) 10 - p. 1874 , 2024
Link:
https://doi.org/10.3390/..
?
9
A Phase Ib Study of Selinexor in Combination with Pembroliz..:
Gouda, Mohamed A.
;
Stephen, Bettzy
;
Tian, Yanyan
...
Journal of Immunotherapy and Precision Oncology. , 2024
Link:
https://doi.org/10.36401..
?
10
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-can..:
Nelson, Blessie Elizabeth
;
Roszik, Jason
;
Ahmed, Jibran
...
Molecular Cancer. 23 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
11
Convergent MAPK pathway alterations mediate acquired resist..:
DiPeri, Timothy P.
;
Zhao, Ming
;
Evans, Kurt W.
...
Journal of Hepatology. 80 (2024) 2 - p. 322-334 , 2024
Link:
https://doi.org/10.1016/..
?
12
ASO Visual Abstract: Axillary Nodal Metastases Conversion a..:
Woodfin, Ashley A.
;
Yam, Clinton
;
Teshome, Mediget
...
Annals of Surgical Oncology. 31 (2024) 4 - p. 2278-2279 , 2024
Link:
https://doi.org/10.1245/..
?
13
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors:
Nelson, Blessie Elizabeth
;
Meric-Bernstam, Funda
Annual Review of Medicine. 75 (2024) 1 - p. 31-48 , 2024
Link:
https://doi.org/10.1146/..
?
14
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TA..:
Subbiah, Vivek
;
Coleman, Niamh
;
Piha-Paul, Sarina A.
...
Cancer Research Communications. 4 (2024) 2 - p. 378-387 , 2024
Link:
https://doi.org/10.1158/..
?
15
Estrogen Receptor Mutations as Novel Targets for Immunother..:
Goldberg, Jonathan
;
Qiao, Na
;
Guerriero, Jennifer L.
...
Cancer Research Communications. , 2024
Link:
https://doi.org/10.1158/..
1-15